QRG Capital Management Inc. Purchases 2,313 Shares of Integer Holdings Co. (NYSE:ITGR)

QRG Capital Management Inc. grew its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 7.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,564 shares of the medical equipment provider’s stock after purchasing an additional 2,313 shares during the quarter. QRG Capital Management Inc.’s holdings in Integer were worth $4,623,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ITGR. Contravisory Investment Management Inc. lifted its stake in Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares during the period. Xponance Inc. grew its holdings in shares of Integer by 4.9% during the second quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after buying an additional 99 shares during the last quarter. Azzad Asset Management Inc. ADV grew its stake in Integer by 0.9% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock valued at $1,504,000 after purchasing an additional 107 shares during the last quarter. GAMMA Investing LLC increased its holdings in Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after buying an additional 142 shares during the period. Finally, Envestnet Portfolio Solutions Inc. increased its stake in shares of Integer by 3.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock worth $689,000 after acquiring an additional 205 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on ITGR. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 target price (up from $125.00) on shares of Integer in a report on Friday, October 25th. Truist Financial reduced their price target on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a research report on Friday, October 25th. KeyCorp raised their price objective on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Citigroup raised their target price on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Finally, Benchmark boosted their price target on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and an average price target of $139.75.

Integer Stock Up 1.7 %

NYSE:ITGR opened at $128.68 on Wednesday. Integer Holdings Co. has a 52 week low of $83.69 and a 52 week high of $133.53. The stock’s fifty day moving average is $128.02 and its two-hundred day moving average is $121.53. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of 39.72, a price-to-earnings-growth ratio of 1.82 and a beta of 1.09. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The business had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.27 earnings per share. Research analysts anticipate that Integer Holdings Co. will post 5.33 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.